Peripheral nervous system diseases 1 Flashcards

1
Q

PNS components

A

 Ventral roots
 Spinal nerve
 Peripheral nerve
 NMJ
 Muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Peripheral nervous system or
Neuromuscular diseases categories

A
  1. Peripheral nerve
  2. Neuromuscular junction
  3. Skeletal muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Peripheral nerve disease (neuropathy)
- what we see?

A

 Reflexes: Decreased / absent
 Reduced / absent muscle tone
 CNs: can be affected
 Neurogenic muscle atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neuromuscular junction disease
(junctionopathy)
- what we see?

A

 Reflexes: Normal / Decreased / Absent
 Diffuse clinical signs vs focal
 Exercise-induced weakness (MG)
 CNs: can be affected
 E.g. Myasthenia gravis, botulism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Muscle disease (myopathy)
- what we see?

A

 Reflexes: Usually normal
 Focal vs Diffuse (exercise intolerance)
 Severe muscle atrophy
 Muscle pain possible
 CNs: usually normal (masticatory ms atrophy)
 E.g. Polymyositis, masticatory muscle myositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mono-neuropathies:
- what can be affected

A

 One nerve affected
> E.g. facial paralysis, radial nerve trauma…
 A group of adjacent nerves affected
> E.g. brachial plexus avulsion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Poly-neuropathies:
- what can be affected?

A

 All limbs affected
 Cranial nerves can be affected
 E.g. coonhound paralysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

main causes of mononeuropathies

A

Traumatic
 Brachial plexus avulsion
 Radial nerve, sciatic nerve damage
<><>
Neoplastic
 Peripheral nerve sheath tumor (PNST)
<><>
Others
 Ischemic neuromyopathy, foraminal IVDH,
inflammatory (abscess, brachial plexus neuritis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Brachial plexus avulsion
- what does it cause? how common?
- what can cause it?

A

 Most common cause of acute thoracic limb
monoparesis / monoplegia
<><><>
 Causes:
◦ Abduction and simultaneous caudal displacement TL
◦ Road traffic accidents, falls from a height

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Brachial plexus avulsion
 Pathogenesis:

A

◦ Traction nerves brachial plexus (C6-T2)
◦ Avulsion nerve roots from spinal cord
> Ventral roots more affected (C6-T2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Brachial plexus avulsion: Clinical signs

A

Acute monoparesis / monoplegia TL
> LMN: C6-T2
 Dragging, knuckling, unable to bear weight
 Absent proprioception
 Decreased/absent spinal reflexes TL
 Hypotonia, neurogenic atrophy
 It is NOT a painful disease!
<><>
Horner’s syndrome (T1-T3)
 Usually partial: Miosis
 Protrusion 3rd eyelid
 Enophtalmos
 Ptosis
<><>
Absent ipsilateral cutaneous trunci (C8-T1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Brachial plexus avulsion: Treatment

A

Supportive:
◦ Prevent contractures, abrasive lesions (dragging)
◦ Keep limb clean and dry
◦ Covering foot with boots, bandages
◦ Treating any wound
◦ Physical therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Brachial plexus avulsion: Prognosis

A

Best predictor: DEEP PAIN
<><>
◦ Preserved: Recommend supportive treatment
<>
◦ Absent: Few chances of recovery
<>
◦ If no improvement during first 2 months: Recovery is unlikely
> Consider AMPUTATION (self-mutilation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atrophy supra/infraspinosus corresponds to what spinal segments?

A

 C5-C7 (suprascapular nerve)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cutaneous trunci: what spinal segments?

A

 C8-T1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Peripheral nerve sheath tumor (PNST)
- Origin
- areas affected
- spread

A

 Origin: Cells surrounding axons in the PNS
 Any peripheral nerve or nerve root
 Common: C6-T2, CN V (trigeminal)
 Slow spread:
◦ Proximally and distally along the nerve
◦ May invade the vertebral canal

17
Q

PNST C6-T2: Clinical signs

A

Lameness vs monoparesis TL:
◦ Unilateral, chronic, progressive
<><><><>
Neurologic dysfunction:
◦ Can take weeks-months before is noticed!
◦ LMN
◦ Absent cutaneous trunci (C8-T1): ipsilateral
◦ Horner’s syndrome (T1-T3): ipsilateral
◦ Rarely on axillary palpation: pain, detectable mass

18
Q

PNST CN V – Trigeminal nerve is affected - signs

A

 Unilateral atrophy masticatory muscles (acute)

19
Q

Polyneuropathies
- what does this mean?
- clinical signs?

A

Multiple peripheral nerves dysfunction
<><>
Clinical signs:
◦ Tetraparesis / tetraplegia (flaccid)
◦ Decreased / absent spinal reflexes
◦ Neurogenic atrophy, unable to lift the head
◦ CNs:
> CN X: dysphonia/aphonia, megaesophagus
> CN VII: facial paralysis

20
Q

Polyneuropathies: Causes
- acute and chronic

A

ACUTE
 Acute idiopathic polyradiculoneuritis
> “Coonhound paralysis”
 DxD: Botulism/Tick paralysis/Acute fulminating MG
<><><><>
CHRONIC
 Multitude reported
> Inherited / Degenerative (breed-related)
> Acquired (progressive)

21
Q

Polyneuropathies: Chronic
- possible causes we see: infectious, metabolic, neoplasia

A
  • Neospora, Toxoplasma
    <>
    Endocrine:
  • Hypothyroidism
  • Diabetes mellitus
    <>
    Paraneoplasitc:
  • Insulinoma
  • Malignant neoplasias
22
Q

Acute idiopathic polyradiculoneuritis
- what is this?
- who gets it?
- pathogenesis
- anatomy affected

A

 “Coonhound paralysis” (CHP)
 Most common in dogs
 Immune-mediated
> Contact with raccoon saliva (1-2w before)
> Post-vaccination
> AIP vs CHP: Same syndrome!
=> CHP: trigger identified
=> AIP: trigger unidentified
 Ventral roots / proximal nerve portion

23
Q

Acute idiopathic polyradiculoneuritis:
Clinical signs

A
  • Rapid generalized LMN paresis (flaccid)
    ◦ Tetraparesis
    ◦ Decreased reflexes
    ◦ Decreased muscle tone
  • PLs and progress to TLs (sometimes opposite)
    <><><><>
    Variable severity:
     Tetraparesis / tetraplegia
     Respiratory paralysis (Life-threatening)
    <><><><>
    CNs:
    1.CN X (dysphonia/aphonia) : common
    2.CN VII (facial paresis): occasionally
     Usually able to urinate/defecate, eat/drink
24
Q

Acute canine polyradiculoneuritis:
 Course of the disease:

A
  1. Initially progressive
     Up to 5-10d post-onset
  2. Stable
     Usually 2-3w (up to 4-6m)
  3. Slow recovery
     Weeks-months (usually complete)
25
Q

Acute canine polyradiculoneuritis:
Diagnosis

A

 History
> Raccon contact, vaccination
 CS
> Acute, progressive, generalized LMN
 Rule-out other causes:
> CBC, biochem profile, UA
> Thoracic radiographs, abdominal Ux
 Support diagnosis:
> Electrodiagnosis: EMG, NCV…
> Muscle / nerve biopsies

26
Q

Acute canine polyradiculoneuritis:
Treatment

A

 Supportive care:
> Frequent turning, padding…
 Physiotherapy
 Monitoring respiratory function
 Do NOT use corticosteroids!

27
Q

Myasthenia gravis
- what is it? forms?
- what do we see?

A

Transmission failure of ACh at the NMJ:
 Congenital form
 Acquired form
<><><><>
EXERCISE-INDUCED WEAKNESS
◦ Normal neurologic examination prior to induction of
exercise-induced weakness
Normal spinal reflexes

28
Q

Myasthenia gravis
- who gets it?
- species, age

A

 Dogs > cats
 Age:
> Bimodal
> 4m-4y vs 9y-13y

29
Q

Myasthenia gravis
 Pathogenesis:

A
  1. Congenital MG: failure of receptors, uncommon
    <><>
  2. Acquired MG:
     Autoimmune: Ab anti-AchR (nicotinic)
     Association with thymoma
     Focal vs generalized clinical syndromes
30
Q

Myasthenia gravis: Diagnosis

A

ACh receptor antibody concentration
 GOLD STANDARD
 High sensitivity (98%) and specificity
 Negative in congenital MG
<><>
Thoracic radiographs:
◦ MEGAESOPHAGUS
◦ Aspiration pneumonia
◦ Cranial thoracic mass
(thymoma)
<><>
Edrophonium chloride test (Tensilon):
 Ultra-short-acting treatment (anti-AChE)
 Dramatic increase in muscle strength
 Frequent false positives and negatives
 Supports presumptive diagnosis
<><>
CBC, biochem profile, UA:
◦ Unremarkable

31
Q

Myasthenia gravis: Treatment

A

Anticholinesterase drugs (anti-AChE)
 Pyridostigmine (0.5-2 mg/kg q8h PO)
 Neostigmine (0.04 mg/kg q6h IM)
<><><><>
Supportive treatment:
 Aspiration pneumonia, gastrostomy tube, respiratory support
<><><><>
Prognosis:
 Guarded
 High incidence aspiration pneumonia (megaesophagus)